• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR
Reimbursement Coverage in France for the use of Confocal Laser Endomicroscopy for Barrett’s Esophagus

Reimbursement Coverage in France for the use of Confocal Laser Endomicroscopy for Barrett’s Esophagus

by Zina | Jun 17, 2019 | News

Announcement of the creation of a new specific procedural code to be added to the Common Classification of Medical Procedures (CCAM) published in the Official Journal of French Republic  Mauna Kea Technologies announced the reimbursement coverage of confocal...

Mauna Kea Technologies announces the exercise of a tranche of €5 million debt with IPF Partners

by Zina | May 29, 2019 | News

Mauna Kea Technologies today announced the exercise of a tranche of €5 million with IPF Partners, as part of the amendment of the Debt Subscription Agreement signed on November 13, 2018. On February 8, 2017, Mauna Kea Technologies announced the Debt...
17 Presentations Highlighting the Clinical Value of Cellvizio® in Gastrointestinal Diseases at the Digestive Disease Week® 2019

17 Presentations Highlighting the Clinical Value of Cellvizio® in Gastrointestinal Diseases at the Digestive Disease Week® 2019

by Zina | May 16, 2019 | News

17 accepted abstracts demonstrate growing clinical recognition of Cellvizio® as a necessary tool for real-time endomicroscopy imaging in multiple gastrointestinal indications  Mauna Kea Technologies today announced the presentation of 17 abstracts supporting...
Positive Results on Needle-Based Endomicroscopy for Real-Time Diagnosis and Staging of Lung Cancer

Positive Results on Needle-Based Endomicroscopy for Real-Time Diagnosis and Staging of Lung Cancer

by Zina | May 6, 2019 | News

Clinical study results published in the European Respiratory Journal demonstrate that lung cancer characteristics can be accurately recognized with Cellvizio® AQ-Flex™ 19 Confocal Miniprobe™ used through fine needles Mauna Kea Technologies today...
17 Presentations Highlighting the Clinical Value of Cellvizio® in Gastrointestinal Diseases at the Digestive Disease Week® 2019

Mauna Kea Technologies Reports First Quarter 2019 Sales

by Zina | Apr 24, 2019 | News

READ THE COMPLETE PRESS RELEASE
« Older Entries
Next Entries »

Articles récents

  • Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 
  • Publication of the 2024 Annual Financial Report 
  • Digestive Disease Week 2025
  • Mauna Kea Technologies Announces Another Milestone Year at Digestive Disease Week® 2025 with 8 Presentations Demonstrating the Clinical Value of Cellvizio® in Key Indications 
  • Mauna Kea Technologies Reports Full Year 2024 Results and Provides a Business Update 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}